Parker, Edward P. K. http://orcid.org/0000-0001-5847-109X
Bronowski, Christina http://orcid.org/0000-0001-8089-4021
Sindhu, Kulandaipalayam Natarajan C. http://orcid.org/0000-0003-2658-0966
Babji, Sudhir
Benny, Blossom
Carmona-Vicente, Noelia
Chasweka, Nedson
Chinyama, End
Cunliffe, Nigel A.
Dube, Queen
Giri, Sidhartha
Grassly, Nicholas C. http://orcid.org/0000-0001-6067-4507
Gunasekaran, Annai
Howarth, Deborah
Immanuel, Sushil
Jere, Khuzwayo C. http://orcid.org/0000-0003-3376-8529
Kampmann, Beate http://orcid.org/0000-0002-6546-4709
Lowe, Jenna
Mandolo, Jonathan
Praharaj, Ira
Rani, Bakthavatsalam Sandya
Silas, Sophia
Srinivasan, Vivek Kumar
Turner, Mark http://orcid.org/0000-0002-5299-8656
Venugopal, Srinivasan
Verghese, Valsan Philip
Darby, Alistair C.
Kang, Gagandeep
Iturriza-Gómara, Miren http://orcid.org/0000-0001-5816-6423
Funding for this research was provided by:
RCUK | Medical Research Council (MR/N006259/1)
Department of Biotechnology, Ministry of Science and Technology
Article History
Received: 3 December 2020
Accepted: 1 November 2021
First Online: 15 December 2021
Competing interests
: M.I.G. has received research grants from GSK and Merck, and has provided expert advice to GSK. K.C.J. and N.A.C. have received investigator-initiated research grant support from GSK. N.A.C. has received research grant support and honoraria for participation in rotavirus vaccine data safety monitoring committee meetings from GSK. All other authors declare no competing interests.